Organogenesis stockholders approve director removal amendment and equity plan increase

Organogenesis Holdings Inc.

Certificate of Incorporation amended to allow director removal without cause by majority vote.
2018 Equity Incentive Plan share reserve increased by 7,826,970 shares.
All 11 director nominees elected; advisory say-on-pay approved with 91.7M for, 12.6M against.
Stockholders selected 1-year frequency for future advisory say-on-pay votes.
Ratification of RSM US LLP as auditor for FY2022 received 117.0M for, 141k against.

item 3.03 item 5.03 item 5.02 item 5.07 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.